Caris Life Sciences (CAI) Debt Ratio (2024 - 2026)

Caris Life Sciences' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.33 for Q1 2026.

• In Q1 2026, Debt Ratio changed N/A year-over-year to 0.33; the TTM figure through Mar 2026 stood at 0.33 (changed N/A YoY), while the FY2025 annual figure was 0.34, down 69.51% from the prior year.
• Debt Ratio was 0.33 for Q1 2026 at Caris Life Sciences, down from 0.34 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.1 in Q4 2024 to a low of 0.33 in Q1 2026.
• Historically, Debt Ratio has averaged 0.51 across 3 years, with a median of 0.38 in 2025.
• Biggest YoY gain for Debt Ratio was 69.51% in 2025; the steepest drop was 69.51% in 2025.
• A 3-year view of Debt Ratio shows it stood at 1.1 in 2024, then tumbled by 69.51% to 0.34 in 2025, then fell by 2.5% to 0.33 in 2026.
• The last three Debt Ratio figures came in at 0.33 (Q1 2026), 0.34 (Q4 2025), and 0.38 (Q3 2025), per Business Quant data.